Association of midgestational paraoxonase 1 activity with pregnancies complicated by preeclampsia

American Journal of Perinatology

Volumn 27, Issue 3, 2010, Pages 205-210

  Baker, Arthur M ^a   Klein, Richard L ^b,c   Haeri, Sina ^a   Moss, Kevin L ^d   Boggess, Kim A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Lipid dysfunction; Oxidative stress; Paraoxonase; Preeclampsia

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; ARYLESTERASE; PARAOXON; PHENYLACETIC ACID;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HUMAN; MATERNAL SERUM; PATHOGENESIS; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SECOND TRIMESTER PREGNANCY;

ADULT; ARYLDIALKYLPHOSPHATASE; CASE-CONTROL STUDIES; FEMALE; HUMANS; OXIDATIVE STRESS; PHENYLACETATES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL CARE; PRENATAL DIAGNOSIS; PROGNOSIS; YOUNG ADULT;

EID: 77449112551     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0029-1236438     Document Type: Article

References (25)

1. Saftlas A F., Olson D R., Franks A L., Atrash H K., Pokras R. Epidemiology of preeclampsia and eclampsia in the United States, 19791986. Am J Obstet Gynecol 1990 163 460-465
2. Centers for Disease Control and Prevention (CDC). Maternal mortalityUnited States, 19821996. MMWR Morb Mortal Wkly Rep 1998 47 705-707
3. Sibai B M., Gordon T, Thom E et al, The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. Am J Obstet Gynecol 1995 172 (2 Pt 1) 642-648
4. Dekker G, Kraayenbrink A. Oxygen free radicals in preeclampsia. Am J Obstet Gynecol 1991 164 273-278
5. Uotila J T., Tuimala R J., Aarnio T M., Pyykkö K A., Ahotupa M O. Findings on lipid peroxidation and antioxidant function in hypertensive complications of pregnancy. Br J Obstet Gynaecol 1993 100 270-276
6. Akyol D, Mungan T, Görkemli H, Nuhoglu G. Maternal levels of vitamin E in normal and preeclamptic pregnancy. Arch Gynecol Obstet 2000 263 151-155
7. Saol S, Ozkinay E, Ozener S. Impaired antioxidant activity in women with pre-eclampsia. Int J Gynaecol Obstet 1999 64 121-127
8. Kharb S. Total free radical trapping antioxidant potential in pre-eclampsia. Int J Gynaecol Obstet 2000 69 23-26
9. Madazli R, Benian A, Aydin S, Uzun H, Tolun N. The plasma and placental levels of malondialdehyde, glutathione and superoxide dismutase in pre-eclampsia. J Obstet Gynaecol 2002 22 477-480
10. Knapen M F., Mulder T P., Van Rooij I A., Peters W H., Steegers E A. Low whole blood glutathione levels in pregnancies complicated by preeclampsia or the hemolysis, elevated liver enzymes, low platelets syndrome. Obstet Gynecol 1998 92 1012-1015
11. Smith G C., Pell J P., Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001 357 2002-2006
12. Irgens H U., Reisaeter L, Irgens L M., Lie R T. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001 323 1213-1217
13. Katabuchi H, Yih S, Ohba T et al. Characterization of macrophages in the decidual atherotic spiral artery with special reference to the cytology of foam cells. Med Electron Microsc 2003 36 253-262
14. Costa L G., Vitalone A, Cole T B., Furlong C E. Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 2005 69 541-550
15. Deakin S, Leviev I, Guernier S, James R W. Simvastatin modulates expression of the PON1 gene and increases serum paraoxonase: a role for sterol regulatory element-binding protein-2. Arterioscler Thromb Vasc Biol 2003 23 2083-2089
16. Durrington P N., Mackness B, Mackness M I. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol 2001 21 473-480
17. Mackness B, Durrington P, McElduff P et al. Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation 2003 107 2775-2779
18. Mackness M I., Harty D, Bhatnagar D et al. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis 1991 86 193-199
19. Mackness B, Mackness M I., Arrol S et al. Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atherosclerosis 1998 139 341-349
20. Dantoine T F., Debord J, Charmes J P. et al. Decrease of serum paraoxonase activity in chronic renal failure. J Am Soc Nephrol 1998 9 2082-2088
21. ACOG Committee on Practice Bulletins - Obstetrics. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002 99 159-167
22. Gan K N., Smolen A, Eckerson H W., La Du B N. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 1991 19 100-106
23. Kumru S, Aydin S, Gursu M F., Ozcan Z. Changes of serum paraoxonase (an HDL-cholesterol-associated lipophilic antioxidant) and arylesterase activities in severe preeclamptic women. Eur J Obstet Gynecol Reprod Biol 2004 114 177-181
24. Uzun H, Benian A, Madazli R, Topuolu M A., Aydin S, Albayrak M. Circulating oxidized low-density lipoprotein and paraoxonase activity in preeclampsia. Gynecol Obstet Invest 2005 60 195-200
25. Sarandöl E, Safak O, Dirican M, Uncu G. Oxidizability of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in preeclampsia. Clin Biochem 2004 37 990-996 (Pubitemid 39388661)